Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft model.

Br J Cancer · 2004 · PMC2409821 · PMID 15199395

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

of borderline significanceP >0.05actually significant

However, the subcutaneous infusion of unencapsulated IUdR did not significantly increase the effect of either dose of FRT, although at the dose of 15 Gy in 5F it was of borderline significance (0.1> P >0.05).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.